Grassley blasts FDA on Vioxx

Sen. Chuck Grassley (R-Iowa) is accusing FDA of muzzling an agency scientist who raised concerns this summer that Vioxx rofecoxib from Merck (MRK) was associated with adverse cardiac events.

On Wednesday, Grassley's staff interviewed David Graham, associate director for science in FDA's Office of Drug Safety,

Read the full 462 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE